Moovcare® is a medical application that needs to be prescribed by your oncologist and helps you stay connected to your medical team. If your physician determines that you are eligible to be included into Moovcare® platform, you will start receiving a digital questionnaire once a week, which you can answer via your smartphone, laptop or tablet.

You will be required to self report your symptoms, Moovcare® algorithm will analyse your answers and if it detects an anomaly or complication, an immediate notification will be sent to your treating physician. Moovcare is a digital therapeutic that uses a simple questionnaire to detect relapse or complications during follow-up of lung cancer patients. It enables monitoring patient symptoms on a weekly basis and alerting medical teams to the first signs of an anomaly. It was founded in 2014 and is based in Jerusalem, Israel.

We are a multidisciplinary team of clinicians, technologists, and behavioral experts united to tackle some of the most significant challenges in healthcare.

Drawing on multi-year clinical studies conducted by leading oncologists in the US and France, we have developed the first digital platform for the early detection of diseases. These studies highlight the impact of patient-reported symptoms on survival and quality of life, forming the foundation of our innovative approach.

500 proprietary risk assessment algorithms focused on early disease risk detection to improve early disease and diagnosis.

Elevate medical practice by earlier disease detection and improved diagnosis via more accurate data collection, better risk and symptom assessment, faster charting, and increased revenue by higher level E&M billing. Now, achieve better outcomes in less time for more money.

Discover SOAP, a patented and clinically validated, Epic, AthenaHealth, etc. EHR-integrated, conversational AI-powered patient and physician-facing interface for more accurate patient data collection and analysis; an unrelenting focus on improving patient outcomes and eliminating administrative burdens. 

Moovcare® was proven in a clinical study to significantly improve lung cancer patients’ well being, as well as the communication with the medical team.

Patented and clinically validated AI-powered new "Gold Standard" of more accurate, truthful and comprehensive patient interviews in less time for more money, risk and symptom assessment, differential diagnosis and note creation.

Patented and clinically validated AI-powered new "Gold Standard" of more accurate, truthful and comprehensive patient interviews in less time for more money, risk and symptom assessment, differential diagnosis and note creation. Less time to provide better care for more money.